Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Research Report 2021

Published: January 2021

No. of Pages: 124

Price:

Single User License: US $ 2900 US $ 2175
Corporate User License: US $ 5800 US $ 4350

Report Description
Table of Contents

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
- AMG-228
- BMS-986156
- FPA-154
- GWN-323
- INCAGN-1876
- Others

Segment by Application
- Melanoma
- Non-Small Cell Lung Cancer
- Gastric Cancer
- Blood Cancer
- Others

By Region
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

By Company
- Ablynx NV
- Amgen Inc
- Apogenix GmbH
- Bristol-Myers Squibb Company
- Five Prime Therapeutics Inc
- Incyte Corp
- MedImmune LLC
- Merck & Co Inc
- Novartis AG
- OncoMed Pharmaceuticals Inc
- Regeneron Pharmaceuticals Inc

Table of Contents

1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Overview
1.1 Product Overview and Scope of Tumor Necrosis Factor Receptor Superfamily Member 18
1.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Type
1.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 AMG-228
1.2.3 BMS-986156
1.2.4 FPA-154
1.2.5 GWN-323
1.2.6 INCAGN-1876
1.2.7 Others
1.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Application
1.3.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Comparison by Application: (2021-2027)
1.3.2 Melanoma
1.3.3 Non-Small Cell Lung Cancer
1.3.4 Gastric Cancer
1.3.5 Blood Cancer
1.3.6 Others
1.4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Estimates and Forecasts
1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2016-2027
1.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2016-2027
1.4.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Region: 2016 Versus 2021 Versus 2027

2 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Competition by Manufacturers
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Manufacturers (2016-2021)
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Sites, Area Served, Product Type
2.5 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Competitive Situation and Trends
2.5.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Tumor Necrosis Factor Receptor Superfamily Member 18 Players Market Share by Revenue
2.5.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario by Region
3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.3.1 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
3.3.2 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.4.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
3.4.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Region
3.5.1 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region
3.5.2 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.6.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
3.6.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.7.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
3.7.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Historic Market Analysis by Type
4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2016-2021)
4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2016-2021)
4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Type (2016-2021)

5 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Historic Market Analysis by Application
5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2016-2021)
5.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application (2016-2021)
5.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Ablynx NV
6.1.1 Ablynx NV Corporation Information
6.1.2 Ablynx NV Description and Business Overview
6.1.3 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Ablynx NV Product Portfolio
6.1.5 Ablynx NV Recent Developments/Updates
6.2 Amgen Inc
6.2.1 Amgen Inc Corporation Information
6.2.2 Amgen Inc Description and Business Overview
6.2.3 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amgen Inc Product Portfolio
6.2.5 Amgen Inc Recent Developments/Updates
6.3 Apogenix GmbH
6.3.1 Apogenix GmbH Corporation Information
6.3.2 Apogenix GmbH Description and Business Overview
6.3.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Apogenix GmbH Product Portfolio
6.3.5 Apogenix GmbH Recent Developments/Updates
6.4 Bristol-Myers Squibb Company
6.4.1 Bristol-Myers Squibb Company Corporation Information
6.4.2 Bristol-Myers Squibb Company Description and Business Overview
6.4.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bristol-Myers Squibb Company Product Portfolio
6.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.5 Five Prime Therapeutics Inc
6.5.1 Five Prime Therapeutics Inc Corporation Information
6.5.2 Five Prime Therapeutics Inc Description and Business Overview
6.5.3 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Five Prime Therapeutics Inc Product Portfolio
6.5.5 Five Prime Therapeutics Inc Recent Developments/Updates
6.6 Incyte Corp
6.6.1 Incyte Corp Corporation Information
6.6.2 Incyte Corp Description and Business Overview
6.6.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Incyte Corp Product Portfolio
6.6.5 Incyte Corp Recent Developments/Updates
6.7 MedImmune LLC
6.6.1 MedImmune LLC Corporation Information
6.6.2 MedImmune LLC Description and Business Overview
6.6.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.4.4 MedImmune LLC Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 Merck & Co Inc
6.8.1 Merck & Co Inc Corporation Information
6.8.2 Merck & Co Inc Description and Business Overview
6.8.3 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Merck & Co Inc Product Portfolio
6.8.5 Merck & Co Inc Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Corporation Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Novartis AG Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 OncoMed Pharmaceuticals Inc
6.10.1 OncoMed Pharmaceuticals Inc Corporation Information
6.10.2 OncoMed Pharmaceuticals Inc Description and Business Overview
6.10.3 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.10.4 OncoMed Pharmaceuticals Inc Product Portfolio
6.10.5 OncoMed Pharmaceuticals Inc Recent Developments/Updates
6.11 Regeneron Pharmaceuticals Inc
6.11.1 Regeneron Pharmaceuticals Inc Corporation Information
6.11.2 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Description and Business Overview
6.11.3 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Regeneron Pharmaceuticals Inc Product Portfolio
6.11.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates

7 Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Cost Analysis
7.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18
7.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors List
8.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Customers

9 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Dynamics
9.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Trends
9.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Growth Drivers
9.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Challenges
9.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Restraints

10 Global Market Forecast
10.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Tumor Necrosis Factor Receptor Superfamily Member 18 by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Tumor Necrosis Factor Receptor Superfamily Member 18 by Type (2022-2027)
10.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Tumor Necrosis Factor Receptor Superfamily Member 18 by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Tumor Necrosis Factor Receptor Superfamily Member 18 by Application (2022-2027)
10.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Tumor Necrosis Factor Receptor Superfamily Member 18 by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Tumor Necrosis Factor Receptor Superfamily Member 18 by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Covered in This Study
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Manufacturers (2016-2021)
Table 7. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Tumor Necrosis Factor Receptor Superfamily Member 18 Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Sites and Area Served
Table 11. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 18 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 18 as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2016-2021)
Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2016-2021)
Table 20. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2016-2021)
Table 22. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2016-2021)
Table 24. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2016-2021)
Table 30. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2016-2021)
Table 32. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2016-2021)
Table 38. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2016-2021)
Table 39. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2016-2021)
Table 40. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (Million US$) by Type (2016-2021)
Table 41. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Type (2016-2021)
Table 42. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2016-2021)
Table 44. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2016-2021)
Table 45. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (Million US$) by Application (2016-2021)
Table 46. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Application (2016-2021)
Table 47. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs) by Application (2016-2021)
Table 48. Ablynx NV Corporation Information
Table 49. Ablynx NV Description and Business Overview
Table 50. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 52. Ablynx NV Recent Developments/Updates
Table 53. Amgen Inc Corporation Information
Table 54. Amgen Inc Description and Business Overview
Table 55. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 57. Amgen Inc Recent Developments/Updates
Table 58. Apogenix GmbH Corporation Information
Table 59. Apogenix GmbH Description and Business Overview
Table 60. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 62. Apogenix GmbH Recent Developments/Updates
Table 63. Bristol-Myers Squibb Company Corporation Information
Table 64. Bristol-Myers Squibb Company Description and Business Overview
Table 65. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 67. Bristol-Myers Squibb Company Recent Developments/Updates
Table 68. Five Prime Therapeutics Inc Corporation Information
Table 69. Five Prime Therapeutics Inc Description and Business Overview
Table 70. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 72. Five Prime Therapeutics Inc Recent Developments/Updates
Table 73. Incyte Corp Corporation Information
Table 74. Incyte Corp Description and Business Overview
Table 75. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 77. Incyte Corp Recent Developments/Updates
Table 78. MedImmune LLC Corporation Information
Table 79. MedImmune LLC Description and Business Overview
Table 80. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 82. MedImmune LLC Recent Developments/Updates
Table 83. Merck & Co Inc Corporation Information
Table 84. Merck & Co Inc Description and Business Overview
Table 85. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 87. Merck & Co Inc Recent Developments/Updates
Table 88. Novartis AG Corporation Information
Table 89. Novartis AG Description and Business Overview
Table 90. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 92. Novartis AG Recent Developments/Updates
Table 93. OncoMed Pharmaceuticals Inc Corporation Information
Table 94. OncoMed Pharmaceuticals Inc Description and Business Overview
Table 95. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 97. OncoMed Pharmaceuticals Inc Recent Developments/Updates
Table 98. Regeneron Pharmaceuticals Inc Corporation Information
Table 99. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 100. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 102. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors List
Table 106. Tumor Necrosis Factor Receptor Superfamily Member 18 Customers List
Table 107. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Trends
Table 108. Tumor Necrosis Factor Receptor Superfamily Member 18 Growth Drivers
Table 109. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Restraints
Table 110. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Type (2022-2027) & (K Pcs)
Table 111. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Application (2022-2027) & (K Pcs)
Table 115. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Region (2022-2027) & (K Pcs)
Table 119. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tumor Necrosis Factor Receptor Superfamily Member 18
Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Type in 2020 & 2027
Figure 3. AMG-228 Product Picture
Figure 4. BMS-986156 Product Picture
Figure 5. FPA-154 Product Picture
Figure 6. GWN-323 Product Picture
Figure 7. INCAGN-1876 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Application in 2020 & 2027
Figure 10. Melanoma
Figure 11. Non-Small Cell Lung Cancer
Figure 12. Gastric Cancer
Figure 13. Blood Cancer
Figure 14. Others
Figure 15. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size 2016-2027 (US$ Million)
Figure 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2016-2027 (K Pcs)
Figure 18. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Manufacturers in 2020
Figure 20. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Tumor Necrosis Factor Receptor Superfamily Member 18 Players: Market Share by Revenue in 2020
Figure 22. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2016-2021)
Figure 24. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region in 2020
Figure 25. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2016-2021)
Figure 26. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region in 2020
Figure 27. U.S. Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. U.A.E Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Type (2016-2021)
Figure 52. Sales Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Application (2016-2021)
Figure 53. Sales Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Application in 2020
Figure 54. Revenue Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Application (2016-2021)
Figure 55. Revenue Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Application in 2020
Figure 56. Manufacturing Cost Structure of Tumor Necrosis Factor Receptor Superfamily Member 18
Figure 57. Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18
Figure 58. Tumor Necrosis Factor Receptor Superfamily Member 18 Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group999115

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Research Report 2021 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...
Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Research Report 2021 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...
Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Research (2015-2019) and Future Forecast (2020-2025) Summary The report forecast global Tumor Necrosis Factor Receptor Superfamily Member 9 market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Tumor ...
Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Analysis 2015-2019 and Forecast 2020-2025 Snapshot The global Tumor Necrosis Factor Receptor Superfamily Member 1A market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The...
Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Analysis 2015-2019 and Forecast 2020-2025 Snapshot The global Tumor Necrosis Factor Receptor Superfamily Member 9 market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The ...
Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Data Survey Report 2015-2025 Summary The global Tumor Necrosis Factor Receptor Superfamily Member 1A market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regiona...
Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Data Survey Report 2015-2025 Summary The global Tumor Necrosis Factor Receptor Superfamily Member 9 market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional...
2020-2025 Global and Regional Tumor Necrosis Factor Receptor Superfamily Member 1A Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report HNY Research projects that the Tumor Necrosis Factor Receptor Superfamily Member 1A market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected fr...
2020-2025 Global and Regional Tumor Necrosis Factor Receptor Superfamily Member 4 Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report HNY Research projects that the Tumor Necrosis Factor Receptor Superfamily Member 4 market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected fro...
2020-2025 Global and Regional Tumor Necrosis Factor Receptor Superfamily Member 9 Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report HNY Research projects that the Tumor Necrosis Factor Receptor Superfamily Member 9 market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected fro...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *